Trial NCT03311334

View at ClinicalTrials.gov 
Org. Study IDs: BBI-DSP7888-102CI

Last trial update was posted on 2024-04-18

MeSH Interventions

Nivolumab Pembrolizumab

MeSH Conditions

Carcinoma Carcinoma, Ovarian Epithelial Carcinoma, Renal Cell Carcinoma, Transitional Cell Fallopian Tube Neoplasms Ovarian Neoplasms

Other Conditions

Fallopian Tube Cancer Platinum-resistant Ovarian Cancer (PROC) Primary Peritoneal Cancer Renal Cell Carcinoma (RCC) Serous Epithelial Ovarian Cancer Urothelial Carcinoma

Stopping Reasons

Sponsor's decision to terminate development of the program.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID